147 related articles for article (PubMed ID: 4573120)
1. Effect of fusaric acid in Parkinson's disease.
Herskovits E; Figueroa Gacitua E
Medicina (B Aires); 1973; 33(1):51-8. PubMed ID: 4573120
[No Abstract] [Full Text] [Related]
2. The clinical use of levodopa in the treatment of Parkinson's disease.
McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
[No Abstract] [Full Text] [Related]
3. A double-blind controlled study of MK-486 in Parkinson's disease.
Schwartz AM; Olanow CW; Spencer A
Trans Am Neurol Assoc; 1973; 98():301-3. PubMed ID: 4594189
[No Abstract] [Full Text] [Related]
4. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
Wycis HT
Confin Neurol; 1972; 34(2):130-5. PubMed ID: 4666056
[No Abstract] [Full Text] [Related]
5. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
Muenter MD
Neurology; 1970 Dec; 20(12):6-13. PubMed ID: 4924343
[No Abstract] [Full Text] [Related]
6. [Management of Parkinson's syndrome using levadopa. Results of a long-term study].
Wälzholz U
Dtsch Med Wochenschr; 1972 Apr; 97(17):686 passim. PubMed ID: 4554502
[No Abstract] [Full Text] [Related]
7. Fusaric acid in Parkinson's disease.
Chase TN
Neurology; 1974 Jul; 24(7):637-9. PubMed ID: 4858086
[No Abstract] [Full Text] [Related]
8. [Disulfiram and L-dopa in patients with Parkinson's syndrome and in torsion dystonia].
Serrano PA; Irigoyen M
Prensa Med Mex; 1972; 37(7):246-50. PubMed ID: 4646433
[No Abstract] [Full Text] [Related]
9. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
Andrews CJ; Somerville B
Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384
[No Abstract] [Full Text] [Related]
10. [Treatment of Parkinson's disease with L-dopa alone or combined with Ro 4-4602].
Barbeau A; Gillo-Joffroy L; Mars H; Arsenault A
Rev Can Biol; 1972; 31():Suppl:169-74. PubMed ID: 5052323
[No Abstract] [Full Text] [Related]
11. [L-Dopa therapy in Parkinson's disease. A double-blind study].
Worm-Petersen J; Dupont E; Mikkelsen B
Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
[No Abstract] [Full Text] [Related]
12. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
Muenter MD
Neurology; 1970 Dec; 20(12):Suppl:6-13. PubMed ID: 4921587
[No Abstract] [Full Text] [Related]
13. [Efficacy and side effects of L-dopa in patients with Parkinson's syndrome].
Lombardo L
Arch Invest Med (Mex); 1973; 4(3):215-24. PubMed ID: 4784173
[No Abstract] [Full Text] [Related]
14. [Combination of L-dopa and sulpiride in the treatment of Parkinson's disease].
Brion S; Guérin R
Cah Med; 1973 Jul; 14(8):695-8. PubMed ID: 4602472
[No Abstract] [Full Text] [Related]
15. Levodopa in Parkinson's disease: effect on pulmonary function.
Nakano KK; Bass H; Tyler HR
Arch Intern Med; 1972 Sep; 130(3):346-8. PubMed ID: 4560177
[No Abstract] [Full Text] [Related]
16. [Treatment of Parkinson's disease with L-dopa. 77 cases].
Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
[No Abstract] [Full Text] [Related]
17. [Contribution to the biochemical treatment of the Parkinson's disease (author's transl)].
Calatayud Maldonado V
Rev Esp Otoneurooftalmol Neurocir; 1978; 36(204):33-41. PubMed ID: 741072
[No Abstract] [Full Text] [Related]
18. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].
Hirayama K; Uono M; Nakanishi T; Kato N; Nagao Y
Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721
[No Abstract] [Full Text] [Related]
19. [Clinical study of L-dopa in Parkinson's disease].
Franken L; Noel G; Lhoas JP; Meyers C; Noel P; Ectors M
Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350
[No Abstract] [Full Text] [Related]
20. [Evaluation of L-DOPA in Parkinsonism with special reference to the study by double-blind method].
Okajima T; Kubota A; Nakahara N; Takeda S; Shimomura K
Naika; 1972; 29(2):335-43. PubMed ID: 4552443
[No Abstract] [Full Text] [Related]
[Next] [New Search]
